MILabs brings outstanding non-invasive imaging performance to today’s increasingly multimodal preclinical research environment. Designed as a scalable all-in-one platform, each modality – PET, SPECT, Optical or CT – whether delivered individually or in any combination, offers performance beyond the capabilities of other in vivo small animal imaging systems.
MILabs is extending its exceptional preclinical SPECT technology to imaging larger subjects. It’s latest G-SPECT – a gyro-free SPECT system – offers < 3 mm isotropic resolution and low-dose dynamic SPECT. As such, G-SPECT enables large animal imaging and is expected to offer groundbreaking clinical SPECT performance for brain, cardiac, general, and pediatric imaging*.
Through its global reach and extensive collaborations with renowned research institutions, MILabs can provide both modular as well as customized imaging solutions for nanomedicine, fully automated 3D autoradiography, high-energy radiotherapy, environmental, archaeological, and agricultural applications as well as the food, chemistry, and process control industries.